<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">51185</article-id><article-id pub-id-type="doi">10.7554/eLife.51185</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Human Biology and Medicine</subject></subj-group></article-categories><title-group><article-title>Apolipoprotein L-1 renal risk variants form active channels at the plasma membrane driving cytotoxicity</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-187502"><name><surname>Giovinazzo</surname><given-names>Joseph A</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-155584"><name><surname>Thomson</surname><given-names>Russell P</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-155585"><name><surname>Khalizova</surname><given-names>Nailya</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-155582"><name><surname>Zager</surname><given-names>Patrick</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3993-9686</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-155583"><name><surname>Malani</surname><given-names>Nirav</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-20680"><name><surname>Rodriguez-Boulan</surname><given-names>Enrique Javier</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-155580"><name><surname>Raper</surname><given-names>Jayne</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-153930"><name><surname>Schreiner</surname><given-names>Ryan</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7457-6606</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="cor3">*</xref><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Biological Sciences</institution>, <institution>Hunter College of the City University of New York</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Margaret Dyson Vision Research Institute</institution>, <institution>Weill Cornell Medicine</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution content-type="dept">Bioinformatics &amp; Data Science</institution>, <institution>Genosity</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff><aff id="aff4"><institution content-type="dept">Dyson Vision Research Institute - Ophthalmology</institution>, <institution>Weill Cornell Medicine</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-43012"><name><surname>Clayton</surname><given-names>Christine</given-names></name><role>Reviewing editor</role><aff><institution>DKFZ-ZMBH Alliance</institution>, <country>Germany</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>joseph.giovinazzo@cuanschutz.edu</email> (JG);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>raper@genectr.hunter.cuny.edu</email> (JR);</corresp><corresp id="cor3"><label>*</label>For correspondence: <email>ryanschreiner@gmail.com</email> (RS);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>19</day><month>05</month><year>2020</year></pub-date><volume>9</volume><elocation-id>e51185</elocation-id><history><date date-type="received"><day>19</day><month>08</month><year>2019</year></date><date date-type="accepted"><day>14</day><month>05</month><year>2020</year></date></history><permissions><copyright-statement>Â© 2020, Giovinazzo et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Giovinazzo et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-51185-v1.pdf"/><abstract><p>Recently evolved alleles of Apolipoprotein L-1 (<italic>APOL1</italic>) provide increased protection against African trypanosome parasites while also significantly increasing the risk of developing kidney disease in humans. APOL1 protects against trypanosome infections by forming ion channels within the parasite, causing lysis. While the correlation to kidney disease is robust, there is little consensus concerning the underlying disease mechanism. We show in human cells that the APOL1 renal risk variants have a population of active channels at the plasma membrane, which results in an influx of both Na<sup>+</sup> and Ca<sup>2+</sup>. We propose a model wherein APOL1 channel activity is the upstream event causing cell death, and that the activate-state, plasma membrane-localized channel represents the ideal drug target to combat APOL1-mediated kidney disease.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000057</institution-id><institution>National Institute of General Medical Sciences</institution></institution-wrap></funding-source><award-id>R01GM34107</award-id><principal-award-recipient><name><surname>Rodriguez-Boulan</surname><given-names>Enrique Javier</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000001</institution-id><institution>National Science Foundation</institution></institution-wrap></funding-source><award-id>IOS-1249166</award-id><principal-award-recipient><name><surname>Raper</surname><given-names>Jayne</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files. Source data files have been provided for all figures in Dryad.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Schreiner R</collab></person-group><year iso-8601-date="2020">2020</year><source>Data from: Apolipoprotein L-1 Renal Risk Variants Form Active Channels at the Plasma Membrane Driving Cytotoxicity</source><ext-link ext-link-type="uri" xlink:href="https://dx.doi.org/10.5061/dryad.p253c6f">https://dx.doi.org/10.5061/dryad.p253c6f</ext-link><comment>Dryad Digital Repository, doi:10.5061/dryad.p253c6f</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-51185-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>